Keegan Peterson, CEO of Cannabis Payroll Provider, Würk, Dies At 33
DENVER – Keegan Peterson, (pictured) CEO of Denver-based cannabis human-resources tech company Würk, has died. He was 33 years old.
Peterson founded Würk in 2015, a payroll and HR-solutions company solely for cannabis businesses with more than 60 employees and clients across 33 states.
“It is with great sadness that I share the news of the passing of our friend and founder Keegan Peterson. Keegan will be remembered for his fierce advocacy in the cannabis space and the company he built to support the industry that he cared about deeply,” wrote Scott Kenyon, executive chair of Würk, in a statement posted on the company’s website.
“He became deeply passionate about building technology solutions for the industry that could help businesses grow and stabilize in order that they could maximize their impact.”
Peterson was a frequent spokesman for the industry and his company was listed by MG Magazine’s as one of the Top 50 Cannabis Employers. Würk also won an Innovation in Technology award in the category of Business Strategies and Innovation from the NCIA.
The company did not provide a cause of death. A memorial fund has been established, and donations will go directly to his wife, Lily Lucas, to help with end-of-life costs and future expenses.
Latest News
Cannabis Extraction Market: An In-depth Analysis from 2018-2027
Douglas, Isle Of Man - Cannabis extraction and extract have gone through exponential growth in the past decade. After being criminalized for a long time, the world saw and moved towards legalizing cannabis in many ...
Bright Green Issues Statement of Intent on Illegal Short Selling Activities
GRANTS, N.M. - Bright Green Corporation (NASDAQ: BGXX) (“Bright Green” or “the Company”), one of the very few companies selected by the U.S. government to grow, manufacture, and sell, legally under federal and state laws, ...
Global Cannabis Testing Market Analysis Report 2023-2030
DUBLIN - Global Cannabis Testing Market to Reach $2.8 Billion by 2030 In the changed post COVID-19 business landscape, the global market for Cannabis Testing estimated at US$1.1 Billion in the year 2022, is projected to reach ...